Drug intelligence / Profile preview

xylitol + grapefruit seed extract

Development stage
Unknown
Lead developer
Xlear
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intranasal
01

Overview

A **combination intranasal spray** containing xylitol and grapefruit seed extract (GSE), most commonly formulated under the brand Xlear, marketed as a drug-free, over-the-counter nasal spray for symptomatic relief of congestion and as an adjunct in respiratory infections. **Xylitol** is a sugar alcohol with known antimicrobial and anti-adhesive properties against bacteria and some viruses, while **Grapefruit Seed Extract** is a citrus-derived mixture containing bioactive compounds (including flavonoids, polyphenols, organic acids), and in commercial GSE, frequently certain quaternary ammonium compounds, believed to confer broad-spectrum antimicrobial, antiviral, and antioxidant activity. The exact antiviral mechanism of this combination is not fully elucidated, but clinical case series and in vitro evidence have suggested **potential virucidal activity against enveloped respiratory viruses, including SARS-CoV-2**, possibly by reducing viral load in the nasal mucosa and limiting pathogen entry via the ACE2-rich nasal epithelium. The spray is typically used as an adjunct, not a replacement for standard of care, and marketed for mild to moderate upper respiratory symptoms. Its safety profile is generally favorable, with no serious safety issues reported in published cases[1][3].

Brand names
Xlear Nasal SprayXlear Rescue Nasal Spray
Other names
xylitol plus grapefruit seed extractxylitol & grapefruit seed extractxylitol and grapefruit seed extract
02

Targets

ACE2 (Angiotensin-converting enzyme 2)Gag (HIV-1 Gag polyprotein)

Beyond the preview

Go deeper on xylitol + grapefruit seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on xylitol + grapefruit seed extract.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call